AU2002239739A1 - Compositions, methods and kits relating to remodelin - Google Patents

Compositions, methods and kits relating to remodelin

Info

Publication number
AU2002239739A1
AU2002239739A1 AU2002239739A AU3973902A AU2002239739A1 AU 2002239739 A1 AU2002239739 A1 AU 2002239739A1 AU 2002239739 A AU2002239739 A AU 2002239739A AU 3973902 A AU3973902 A AU 3973902A AU 2002239739 A1 AU2002239739 A1 AU 2002239739A1
Authority
AU
Australia
Prior art keywords
remodelin
compositions
methods
kits relating
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239739A
Other languages
English (en)
Inventor
Robert Friesel
Volkhard Linder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maine Medical Center Research Institute
Original Assignee
Maine Medical Center Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maine Medical Center Research Institute filed Critical Maine Medical Center Research Institute
Publication of AU2002239739A1 publication Critical patent/AU2002239739A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002239739A 2000-10-19 2001-10-19 Compositions, methods and kits relating to remodelin Abandoned AU2002239739A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/692,081 2000-10-19
US09/692,081 US6630325B1 (en) 2000-10-19 2000-10-19 Compositions, methods and kits relating to remodel
PCT/US2001/050940 WO2002042487A2 (en) 2000-10-19 2001-10-19 Compositions, methods and kits relating to remodelin

Publications (1)

Publication Number Publication Date
AU2002239739A1 true AU2002239739A1 (en) 2002-06-03

Family

ID=24779171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239739A Abandoned AU2002239739A1 (en) 2000-10-19 2001-10-19 Compositions, methods and kits relating to remodelin

Country Status (5)

Country Link
US (3) US6630325B1 (de)
EP (1) EP1409507A4 (de)
AU (1) AU2002239739A1 (de)
CA (1) CA2426477A1 (de)
WO (1) WO2002042487A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7414112B2 (en) * 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US20050147602A1 (en) * 2000-10-19 2005-07-07 Maine Medical Center Research Institute Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
EP2305710A3 (de) 2002-06-03 2013-05-29 Genentech, Inc. Synthetische Antikörperphagenbibliotheken
UA80295C2 (en) 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
NZ584848A (en) 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
US9050296B2 (en) 2012-07-03 2015-06-09 Maine Medical Center Methods for treating metabolic syndrome with Cthrc1 polypeptide
AU2015205370B2 (en) 2014-01-10 2017-11-30 Glaxosmithkline Intellectual Property (No.2) Limited Hydroxy formamide derivatives and their use
CN105886515A (zh) * 2016-03-24 2016-08-24 南开大学 特异结合乏氧肝癌单抗h103轻、重链可变区基因及其应用
CN110051841B (zh) * 2019-05-28 2021-02-02 北京大学 Nat10抑制剂在制备用于抑制hif表达的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
EP1039801A4 (de) * 1997-06-06 2003-03-26 Human Genome Sciences Inc 207 menschliche sekretierte proteine
EP1100869A4 (de) * 1998-07-30 2005-04-27 Human Genome Sciences Inc 98 menschliche sekretierte proteine
AU5677399A (en) * 1998-08-20 2000-03-14 Wistar Institute Of Anatomy And Biology, The Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
WO2000052151A2 (en) * 1999-03-05 2000-09-08 Incyte Pharmaceuticals, Inc. Human secretory proteins
US20040146862A1 (en) * 2000-03-15 2004-07-29 Eos Biotechnology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2001271973A1 (en) * 2000-07-20 2002-02-05 Kevin P. Baker Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis

Also Published As

Publication number Publication date
CA2426477A1 (en) 2002-05-30
EP1409507A2 (de) 2004-04-21
WO2002042487A2 (en) 2002-05-30
EP1409507A4 (de) 2006-07-12
WO2002042487A3 (en) 2004-02-26
US20040063176A1 (en) 2004-04-01
US20020161211A1 (en) 2002-10-31
US6630325B1 (en) 2003-10-07

Similar Documents

Publication Publication Date Title
AU2001268126A1 (en) Compositions, kits, and methods for promoting defined health benefits
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001258801A1 (en) Gelling composition
AU2002234076A1 (en) Construction composition, structure, and method
AU2001219651A1 (en) Mulch composition and method
AU2001294132A1 (en) Alcohol-free perfuming composition
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
WO2005110009A8 (en) COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001233932A1 (en) Method and composition
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2001241677A1 (en) Pre-shampoo conditioning composition
AU2002223761A1 (en) Thickening composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001275201A1 (en) Acne-treating composition
AU2001287852A1 (en) Composition
AU2002322515A1 (en) Compositions, methods, and kits related to treating and diagnosing hypertension
AU2001234548A1 (en) Compositions, kits, and methods for cardiovascular health
AU2001232075A1 (en) Compound, composition and use
AU2002239775A1 (en) Chemical-library composition and method
AU2001235764A1 (en) Compositions